AI assistant
Sending…
Aclaris Therapeutics, Inc. — Director's Dealing 2016
Sep 3, 2016
33670_dirs_2016-09-02_4036f5a6-0293-4cc5-b681-7160b03365c1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Aclaris Therapeutics, Inc. (ACRS)
CIK: 0001557746
Period of Report: 2016-09-01
Reporting Person: Humphries William D. (Director)
More from Aclaris Therapeutics, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 7
Earnings Release
2026
May 7
Investor Presentation
2026
Apr 28
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Major Shareholding Notification
2026
Mar 26
Major Shareholding Notification
2026
Mar 17
Director's Dealing
2026
Mar 3
Annual Report
2026
Feb 26